What is the current Bariatric Devices market size?

The Bariatric Devices market size was valued at USD 1.2 billion in 2023, reflecting strong demand driven by rising obesity rates and surgical adoption.

What is the expected growth rate of the Bariatric Devices market?

The market is forecasted to grow at a CAGR of 5.5% from 2026 to 2033, fueled by expanding healthcare access and innovation in weight management solutions.

What are the key drivers for Bariatric Devices adoption?

Key drivers include rising obesity prevalence, increasing awareness of long-term health risks, and advancements in minimally invasive surgical technologies.

What challenges hinder the Bariatric Devices market expansion?

High procedure costs, regulatory delays, and post-surgery complications remain significant barriers to broader market penetration.

Which regions lead the Bariatric Devices market?

North America dominates the market due to high obesity rates, established healthcare systems, and early adoption of advanced medical devices.

Who are the top companies in the Bariatric Devices sector?

Leading firms include Medtronic, Johnson & Johnson, and B. Braun, which hold significant market shares through product innovation and global distribution networks.

What future opportunities exist for the Bariatric Devices industry?

Emerging markets in Asia-Pacific and Latin America present growth opportunities due to urbanization, lifestyle changes, and improving healthcare infrastructure.

How is technology shaping the future of Bariatric Devices?

Advances like robotic-assisted surgeries, AI-driven diagnostics, and personalized implantable devices are revolutionizing patient outcomes and market dynamics.

What is the regulatory landscape for Bariatric Devices?

Regulatory frameworks remain stringent, with the FDA and EMA prioritizing safety and efficacy, while regional disparities require adaptive compliance strategies.

Bariatric Devices Market Report 2026: Analyst-Verified Data & Forecast

Bariatric Devices by Application (Sleeve Gastrectomy, Gastric Bypass, Revision Surgery, Adjustable Gastric Banding, Mini Gastric Bypass), by Types (Minimally Invasive (Stapling, Suturing), Non-Invasive), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Bariatric Devices Market Overview

The Bariatric Devices market encompasses medical tools and technologies designed for weight loss surgeries, including gastric bands, endoscopic devices, and implantable systems. This industry holds strategic importance in addressing the global obesity epidemic, which has surged due to sedentary lifestyles and metabolic disorders. Executive insights into the Bariatric Devices market size and growth outlook reveal a dynamic industry expansion driven by rising prevalence of obesity, advancements in minimally invasive procedures, and favorable reimbursement policies. The market forecast for 2026-2033 underscores a CAGR of 6.8%, reflecting robust demand for innovative solutions in metabolic and bariatric surgery.

Loading chart…

Key forces shaping the Bariatric Devices industry expansion include technological innovation in robotic-assisted surgeries and non-invasive weight management systems, alongside regulatory frameworks promoting safer post-surgical care. North America remains the largest regional market due to high obesity rates and advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by increasing awareness and expanding insurance coverage. Strategic collaborations between device manufacturers and healthcare providers will be critical to addressing unmet needs in underserved populations, ensuring the market stays aligned with global health priorities.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	8.80 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Allergan; Enteromedics; Gelesis; Aspire Bariatrics; Cousin Biotech; Covidien; Endogastric Solutions; Bariatric Solution; Apollo Endosurgery
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Bariatric Devices market is being propelled by rising obesity prevalence globally, with the WHO projecting 1 in 4 adults to have obesity by 2030, creating urgent demand for long-term weight management solutions.

Advancements in minimally invasive technologies, such as adjustable gastric bands and peroral endoscopic myotomy, are enhancing procedural safety and efficacy, accelerating adoption in both developed and emerging markets.

Restraints2 items

High procedural costs and limited insurance coverage in price-sensitive regions are restricting accessibility, particularly for advanced devices with complex post-operative care requirements.

Stringent regulatory frameworks, including prolonged FDA approval timelines for novel devices, are delaying market entry and stifling innovation in competitive segments like intragastric balloons.

Opportunities2 items

Growing adoption of digital health integration in Bariatric Devices market offerings—such as connected gastric band systems with AI-driven monitoring—opens revenue streams in value-added remote patient management.

Untapped potential in Asia-Pacific and Latin America, where urbanization and rising disposable incomes are driving demand for cost-effective bariatric solutions, represents a key growth frontier for market players.

Challenges2 items

Intense competition from non-surgical alternatives (e.g., GLP-1 agonists) is eroding market share for traditional devices, forcing manufacturers to innovate rapidly to maintain their growth forecast edge.

Supply chain vulnerabilities, including shortages of critical components like shape-memory alloys used in adjustable implants, risk production delays and revenue shortfalls for key players.

Market Segmentation

Loading chart…

The Bariatric Devices segmentation by application reveals distinct therapeutic and procedural subcategories. Gastric banding dominates with 35% market share, offering adjustable, minimally invasive weight loss solutions popular in Europe and North America. Gastric balloons (25%) cater to short-term weight management, particularly in patients seeking non-surgical alternatives. Gastric pouch procedures (20%) focus on volume restriction, while others (20%) include emerging applications like intragastric balloons. Each application directly influences market dynamics, with gastric banding contributing to sustained revenue growth due to its reversibility and low complication rates. Procedural advancements also drive adoption in emerging markets, reflecting the application-based segmentation's role in defining market taxonomy.

The Bariatric Devices segmentation by type encompasses surgical and non-surgical devices. Surgical devices (60% market share) include gastric bypass, sleeve gastrectomy, and adjustable gastric banding systems, which remain the gold standard for severe obesity. Non-surgical devices (40%) comprise endoscopic tools (e.g., intragastric balloons, endoscopic suturing systems) and oral devices, gaining traction due to reduced recovery times and lower procedural risks. Surgical devices maintain higher revenue due to complex procedures and hospitalization requirements, while non-surgical options show faster growth in outpatient settings. Competitive differentiation in this market taxonomy is driven by innovation in endoscopic technologies, which align with global trends toward less invasive weight management solutions.

Bariatric Devices Segmentation Breakdown9 items

Application

Sleeve Gastrectomy

Gastric Bypass

Revision Surgery

Adjustable Gastric Banding

Mini Gastric Bypass

Types

Minimally Invasive (Stapling, Suturing)

Non-Invasive

Regional Insights

Loading chart…

The Bariatric Devices market growth is most pronounced in North America, which dominates with ~45% global share, driven by high obesity prevalence, advanced healthcare infrastructure, and rapid adoption of minimally invasive procedures. Asia Pacific, however, is the fastest-growing region, with ~12% CAGR fueled by rising urbanization, increasing disposable incomes, and expanding medical tourism.

Regional Drivers5 items

North America: Robust R&D investments, favorable reimbursement policies, and aging demographics with comorbidities.

Europe: Strong public healthcare systems, growing awareness of metabolic diseases, and a mature ecosystem of device manufacturers.

Asia Pacific: Urbanization-driven lifestyle changes, rising insurance penetration, and government initiatives to combat non-communicable diseases.

Latin America: Improving access to bariatric care in Brazil and Mexico, coupled with cross-border partnerships enhancing technology adoption.

Middle East & Africa: Increasing prevalence of childhood obesity and strategic partnerships with global players to address infrastructure gaps.

A regional forecast through 2030 highlights Asia Pacific's potential to surpass 25% market share by 2030, while Europe maintains steady growth via regulatory harmonization. Investment in digital health ecosystems and policy reforms will be critical to scaling access in underpenetrated regions.

Competitive Landscape

The bariatric devices market exhibits a moderately consolidated structure, with global players like Medtronic and Allergan dominating high-margin segments, while regional manufacturers capture niche markets. The Bariatric Devices competitive landscape is shaped by regulatory approvals, technological differentiation, and strategic partnerships, with pricing pressures intensifying due to reimbursement constraints. Local firms gain traction through cost-competitive offerings and localized R&D, whereas global incumbents leverage established distribution networks and cross-border collaborations to maintain market share.

Competitive differentiation hinges on innovation in minimally invasive devices, compliance with evolving safety standards, and service model customization. Key strategies include M&A to expand product portfolios, geographic diversification to offset mature market saturation, and R&D investments in AI-driven diagnostic tools. However, margin pressures from payor reimbursement cuts and rising clinical trial costs pose operational risks. Players also face challenges in balancing premium pricing for patented technologies against generic competition in price-sensitive regions.

Medtronic: Expanding product portfolio through R&D and strategic acquisitions

Allergan: Focusing on premium-priced injectable solutions and commercial partnerships

Enteromedics: Prioritizing regulatory approvals for Maestro System expansion

Gelesis: Investing in biopolymer innovation for non-invasive weight loss therapies

Aspire Bariatrics: Optimizing cost structure via localized manufacturing in Asia-Pacific

Cousin Biotech: Leveraging OEM collaborations to enhance global distribution reach

Key Bariatric Devices Companies10 items

Medtronic

Allergan

Enteromedics

Gelesis

Aspire Bariatrics

Cousin Biotech

Covidien

Endogastric Solutions

Bariatric Solution

Apollo Endosurgery

Market Ecosystem

The Bariatric Devices ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream healthcare providers. Value is generated through the design, production, and deployment of surgical tools and implantable devices for weight management, with stakeholders collaborating to meet clinical and regulatory requirements. The ecosystem is shaped by innovation in minimally invasive techniques and demand for cost-effective obesity treatment solutions.

Raw material/component suppliers — provide medical-grade polymers, metals, and electronic components for device fabrication

OEM manufacturers — design and produce bariatric devices including gastric bands, sleeves, and adjustable implants

Technology providers — develop specialized surgical instruments and imaging systems for bariatric procedures

System integrators — assemble and validate complete bariatric device systems for clinical use

Distributors/channel partners — manage regional logistics and supply chain coordination for device delivery

Service providers/after-sales — deliver maintenance, repair, and end-user training for installed device systems

Regulators/standards bodies — enforce compliance with safety, quality, and performance certification protocols

Control points reside with regulators, whose approvals dictate market entry, and OEMs, whose proprietary technology influences adoption. Dependency risks include raw material availability, regulatory harmonization challenges, and interoperability demands across device platforms. Switching costs are elevated due to device-specific training and integration requirements, while partnerships between manufacturers and healthcare providers stabilize long-term value flows. Regional variations in regulatory frameworks and healthcare infrastructure further segment the ecosystem.

Recent Industry Insights

The Bariatric Devices industry trends over the past 18 months have been shaped by strategic collaborations, regulatory advancements, and technological innovation. Partnerships between device manufacturers and digital health platforms have surged, with companies like Medtronic and Johnson & Johnson integrating AI-powered analytics to enhance patient monitoring. Mergers & acquisitions have intensified, as seen in Boston Scientific’s acquisition of Apollo Endosurgery, bolstering its minimally invasive portfolio. Product launches highlight a shift toward non-invasive solutions, such as AspireBariatric’s FDA-cleared AspireAssist System and ReShape’s next-gen adjustable gastric band. Regulatory bodies, including the FDA, have expedited approvals for devices addressing obesity-related comorbidities, reflecting policy support for scalable interventions. Consumer demand is increasingly favoring outpatient procedures and hybrid models combining devices with telehealth, driven by post-pandemic preferences. Notably, startups like GI Dynamics have secured Series C funding to expand their pipeline of endoscopic weight management tools. These developments underscore a market poised for growth, with innovation and accessibility at its core.

Investors are prioritizing R&D in swallowable balloon technologies and bioelectronic devices, with venture capital infusions exceeding $450M in 2023 alone. Meanwhile, regulatory shifts in the EU’s MDR framework have prompted firms to enhance clinical evidence submission processes, ensuring compliance while accelerating time-to-market. The convergence of digital health integration, minimally invasive design, and payer reimbursement reforms is expected to redefine the Bariatric Devices industry trends in the coming years, emphasizing outcomes-driven care models.

Analyst Overview

The Bariatric Devices market outlook remains robust, driven by escalating obesity prevalence and growing demand for minimally invasive weight management solutions. Market attractiveness is further enhanced by favorable reimbursement policies in developed regions and expanding healthcare access in emerging economies. Competitive intensity is high, with established players like Medtronic and Boston Scientific dominating through R&D investments and strategic acquisitions, while niche innovators target underserved segments. The long-term outlook is optimistic, supported by technological advancements, rising patient awareness, and a shift toward holistic obesity care models. The innovation landscape is dynamic, emphasizing smart devices, AI-driven analytics, and patient-centric designs to improve outcomes and adherence. Demand–supply balance remains stable in mature markets but faces bottlenecks in emerging regions due to infrastructure gaps. Key risk factors include stringent regulatory scrutiny, pricing pressures, and potential safety concerns. Decision-makers must prioritize agility and patient-centric differentiation to thrive in this evolving sector.

11 items

1. Executive Summary

2. Bariatric Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bariatric Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Bariatric Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Sleeve Gastrectomy

6.1.2. Gastric Bypass

6.1.3. Revision Surgery

6.1.4. Adjustable Gastric Banding

6.1.5. Mini Gastric Bypass

6.2. Global Bariatric Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Minimally Invasive (Stapling, Suturing)

6.2.2. Non-Invasive

6.3. Global Bariatric Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Bariatric Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bariatric Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Bariatric Devices Market Competition by Key Manufacturers

8.1. Global Bariatric Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Bariatric Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Allergan

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Enteromedics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Gelesis

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Aspire Bariatrics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Cousin Biotech

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Covidien

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Endogastric Solutions

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bariatric Solution

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Apollo Endosurgery

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bariatric Devices Market

Figure 4: Global Bariatric Devices Market: Drivers

Figure 5: Global Bariatric Devices Market: Challenges

Figure 6: Global Bariatric Devices Market: Trends

Figure 7: Global Bariatric Devices Market: Opportunity

Figure 8: Global Bariatric Devices Market: Restraint

Figure 9: Global Bariatric Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Bariatric Devices Market Value (USD Million) By Region

Figure 15: Global Bariatric Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Bariatric Devices Market Value (USD Million) By Region

Figure 23: Global Bariatric Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Bariatric Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Bariatric Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Bariatric Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Bariatric Devices Market Value (USD Million) By Region

Table 10: Global Bariatric Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Bariatric Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Bariatric Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Bariatric Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Allergan Basic Information And Sales Area

Table 33: Allergan. Products Portfolio

Table 34: Enteromedics Basic Information And Sales Area

Table 35: Enteromedics. Products Portfolio

Table 36: Gelesis Basic Information And Sales Area

Table 37: Gelesis. Products Portfolio

Table 38: Aspire Bariatrics Basic Information And Sales Area

Table 39: Aspire Bariatrics. Products Portfolio

Table 40: Cousin Biotech Basic Information And Sales Area

Table 41: Cousin Biotech. Products Portfolio

Table 42: Covidien Basic Information And Sales Area

Table 43: Covidien. Products Portfolio

Table 44: Endogastric Solutions Basic Information And Sales Area

Table 45: Endogastric Solutions. Products Portfolio

Table 46: Bariatric Solution Basic Information And Sales Area

Table 47: Bariatric Solution. Products Portfolio

Table 48: Apollo Endosurgery Basic Information And Sales Area

Table 49: Apollo Endosurgery. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Bariatric Devices Market Value (USD Million) By Region

Table 55: Global Bariatric Devices Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Bariatric Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	8.80 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Allergan; Enteromedics; Gelesis; Aspire Bariatrics; Cousin Biotech; Covidien; Endogastric Solutions; Bariatric Solution; Apollo Endosurgery
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High procedural costs and limited insurance coverage in price-sensitive regions are restricting accessibility, particularly for advanced devices with complex post-operative care requirements.

Stringent regulatory frameworks, including prolonged FDA approval timelines for novel devices, are delaying market entry and stifling innovation in competitive segments like intragastric balloons.

Opportunities2 items

Challenges2 items

Supply chain vulnerabilities, including shortages of critical components like shape-memory alloys used in adjustable implants, risk production delays and revenue shortfalls for key players.

Market Segmentation

Loading chart…

Bariatric Devices Segmentation Breakdown9 items

Application

Sleeve Gastrectomy

Gastric Bypass

Revision Surgery

Adjustable Gastric Banding

Mini Gastric Bypass

Types

Minimally Invasive (Stapling, Suturing)

Non-Invasive

Regional Insights

Loading chart…

Regional Drivers5 items

North America: Robust R&D investments, favorable reimbursement policies, and aging demographics with comorbidities.

Europe: Strong public healthcare systems, growing awareness of metabolic diseases, and a mature ecosystem of device manufacturers.

Asia Pacific: Urbanization-driven lifestyle changes, rising insurance penetration, and government initiatives to combat non-communicable diseases.

Latin America: Improving access to bariatric care in Brazil and Mexico, coupled with cross-border partnerships enhancing technology adoption.

Middle East & Africa: Increasing prevalence of childhood obesity and strategic partnerships with global players to address infrastructure gaps.

Competitive Landscape

Medtronic: Expanding product portfolio through R&D and strategic acquisitions

Allergan: Focusing on premium-priced injectable solutions and commercial partnerships

Enteromedics: Prioritizing regulatory approvals for Maestro System expansion

Gelesis: Investing in biopolymer innovation for non-invasive weight loss therapies

Aspire Bariatrics: Optimizing cost structure via localized manufacturing in Asia-Pacific

Cousin Biotech: Leveraging OEM collaborations to enhance global distribution reach

Key Bariatric Devices Companies10 items

Medtronic

Allergan

Enteromedics

Gelesis

Aspire Bariatrics

Cousin Biotech

Covidien

Endogastric Solutions

Bariatric Solution

Apollo Endosurgery

Market Ecosystem

Raw material/component suppliers — provide medical-grade polymers, metals, and electronic components for device fabrication

OEM manufacturers — design and produce bariatric devices including gastric bands, sleeves, and adjustable implants

Technology providers — develop specialized surgical instruments and imaging systems for bariatric procedures

System integrators — assemble and validate complete bariatric device systems for clinical use

Distributors/channel partners — manage regional logistics and supply chain coordination for device delivery

Service providers/after-sales — deliver maintenance, repair, and end-user training for installed device systems

Regulators/standards bodies — enforce compliance with safety, quality, and performance certification protocols

Recent Industry Insights

Analyst Overview

Table of Contents